PGX
- Product code
- PGX
- Device name
- Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.2680
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 2
- Summaries archived here
- 2 (direct download)
- 510(k) clearances (all years, FDA)
- 15 (all years; only the last 3 years are listed here)
FDA classification definition
An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K260047 | 2026-08-28 | Roche Molecular Systems, Inc. | cobas Strep A Nucleic acid test for use on the cobas… | |
| K260333 | 2026-06-15 | Diasorin Molecular, LLC | LIAISON NES Group A Strep; LIAISON NES Group A Strep… |
Official FDA classification page: PGX
Classification and pathway per current FDA publications. Data from openFDA (CC0).